Neusilin® US2 is a fine ultra light granule of magnesium aluminometasilicate and is widely accepted as a multifuntional excipient that improves the quality of pharmaceuticals. Due to its large surface area and porous nature, US2 adsorbs high loads of oils or water and can be mechanically compacted into high quality tablets. Furthermore, Fuji's unique manufacturing expertise makes US2 neutral unlike traditional Magnesium aluminum silicates whose pH is alkaline. In this newsletter we introduce you to the best disintegrant combination with Neusilin® US2 for tabletting.



 

PROPERTY

Grade US2(Granule)

Loss on Drying (%)

1.4

Bulk Density - Loose (g/ml)

0.15

Bulk Density - Tapped (g/ml)

0.19

True Specific Gravity (g/ml)

2.2

BET Specific Surface Area (m2/g)

300

Mean Particle Size (m)  (Agglomerate)

60 - 120

Angle of Repose (Degrees)

30

Oil Adsorbing Capacity (ml/g)

3.2

pH of 5% Slurry

7.4

Packaging (Kg)

10

 

Among excipients, disintegrants play an improtant role in disintegration and dissolution of tablets. This factor is critical for drug absorption in vivo. In order to give the formulators the best choice of disintegrating agent in combination with Neusilin® US2, eight most common disintegrants were selected and their ability to quickly disintegrate compressed tablets was evaluated.


 

Carboxy methyl starch sodium (Explotab)

Croscarmellose sodium (Ac-Di-Sol)

Corn starch

Cross-link polyvinylpyrrolidone (Kollidon-CL)

Carmellose calcium (ECG-505)

Rice starch (Microperl)

Hydroxy propyl cellulose (LH-21)

Carboxy methyl cellulose (NS-300)

 


 

Neusilin® US2 was compounded with 5% disintegrant and 1% Magnesium stearate. The mixture was compressed into tablets of 11 mm dia and 200mg weight in a rotary tabletting machine. Disintegration test was carried out as per JP. To measure the disintegration time, one tablet is placed in each tube in the basket rack assembly containing six glass tubes, 7.75 cm long, open at the top and with a 1.8~2.2mm mesh, attached to the bottom. The assembly is positioned in a 1-liter beaker of water and maintained at 37C. The basket rack is moved up and down at constant speed and the disintegration time was calculated as the time taken for the tablet to disintegrate and all the particles pass through the mesh screen. The results are summarized in the table given below.

 

 

Hardness (Newton) at

Tablet thickness (mm)at

Disintegration time (min:sec)

Compression Pressure

250K

375K

500K

250K

375K

500K

250K

375K

500K

Neusilin alone

108.7

142.1

161.3

5.191

4.559

4.187

> 30:00

> 30:00

> 30:00

Neu* + Explotab

95.9

130.1

144.8

5.064

4.478

4.12

> 30:00

> 30:00

> 30:00

Neu+ Corn Starch

107.5

105.8

94.7

5.033

4.483

4.126

> 30:00

> 30:00

> 30:00

Neu + ECG-505

111.4

156.9

154

5.022

4.493

4.124

00:50

02:17

02:00

Neu+ LH-21

105.8

119.1

135.5

5.027

4.47

4.108

15:47

25:11

19:47

Neu + Ac-Di-Sol

102.7

131.4

143.2

5.022

4.478

4.105

00:18

00:18

00:18

Neu+ Kollidon-CL

105.1

125.3

118.7

5.078

4.514

4.151

01:16

02:01

02:17

Neu + Microperl

94.8

115.4

134.3

5.084

4.501

4.131

>30:00

>30:00

>30:00

Neu + CMC

97.8

128.9

144

5.103

4.496

4.133

26:52

18:30

18:45

 

*Neu=Neusilin

 

 

Among the common disintegrants used, the most compatible disintegrant with Neusilin® US2 was found to be Croscarmellose sodium (Ac-Di-Sol) followed by Cross-link polyvinylpyrrolidone (Kollidon-CL) and Carmellose calcium (ECG-505). The Characteristics (large surface area and porus nature) of US2 and the cross linking of Croscarmellose sodium act synergestically allowing the tablet to swell and absorb many times it weight in water leading to quick disintegration. Neusilin® US2 improves flowability and make sufficiently hard tablets at low compression forces. Increase in hardness and compression pressure did not affect the disintegration time or tablet conformity when Croscarmellose sodium was used as a disintegrant.

 

As most of the starch type disintegrants does not go well with Neusilin® US2, Croscarmellose sodium is your best choice when you choose Neusilin® US2 in your formulations.

 


Dosage and Safety:
Neusilin®
is extremely safe with no reports of adverse reactions and is listed in the US Pharmacopeia/ National Formulary and Japanese Pharmaceutical Codex. Please consult Fuji technical sales team for your specific requirements.

Neusilin® is available in various grades to meet the diverse requirements of complex actives that can be converted to oral solid-dosage forms. To obtain a sample or to find your local distributor, please contact us at pharma@fujichemical.co.jp.  For more technical information, please visit www.fujichemical.co.jp/english/neusilin.html

 

 

If you would prefer not to receive email newsletter, or you’ve changed your email address, please click here

Information found is presented in good faith and no guarantee or obligation as to accuracy and no assumption of liability. The information herein does not imply a performance warranty. Purchasers should decide the suitability of the product with respect to their desired application and purpose.